» Articles » PMID: 29322405

Combining Cell Type-Restricted Adenoviral Targeting with Immunostaining and Flow Cytometry to Identify Cells-of-Origin of Lung Cancer

Overview
Specialty Molecular Biology
Date 2018 Jan 12
PMID 29322405
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancers display considerable intertumoral heterogeneity, leading to the classification of distinct tumor subtypes. Our understanding of the genetic aberrations that underlie tumor subtypes has been greatly enhanced by recent genomic sequencing studies and state-of-the-art gene targeting technologies, highlighting evidence that distinct lung cancer subtypes may be derived from different "cells-of-origin". Here, we describe the intra-tracheal delivery of cell type-restricted Ad5-Cre viruses into the lungs of adult mice, combined with immunohistochemical and flow cytometry strategies for the detection of lung cancer-initiating cells in vivo.

Citing Articles

On Target: An Intrapulmonary Transplantation Method for Modelling Lung Tumor Development in its Native Microenvironment.

McDonald J, Scott L, Van Zuylekom J, Holloway S, Blyth B, Sutherland K Methods Mol Biol. 2023; 2691:31-41.

PMID: 37355535 DOI: 10.1007/978-1-0716-3331-1_3.


Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis.

Gangoda L, Schenk R, Best S, Nedeva C, Louis C, DSilva D Cell Death Differ. 2021; 29(1):96-104.

PMID: 34304242 PMC: 8738744. DOI: 10.1038/s41418-021-00839-3.


Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.

Best S, Vandenberg C, Abad E, Whitehead L, Guiu L, Ding S Cell Death Dis. 2020; 11(10):877.

PMID: 33082333 PMC: 7575595. DOI: 10.1038/s41419-020-03066-9.


Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma.

Best S, Ding S, Kersbergen A, Dong X, Song J, Xie Y Nat Commun. 2019; 10(1):4190.

PMID: 31519898 PMC: 6744438. DOI: 10.1038/s41467-019-12164-y.


Studying the immune landscape in lung cancer models: choosing the right experimental tools.

Weeden C, Ah-Cann C, Asselin-Labat M Transl Lung Cancer Res. 2018; 7(Suppl 3):S248-S250.

PMID: 30393614 PMC: 6193919. DOI: 10.21037/tlcr.2018.09.05.